Comprehensive Vutrisiran Market Research: Forecast, Trends, and Industry Outlook
The Vutrisiran market was valued at USD 0.5 billion in 2024 and is projected to reach USD 1.5 billion by 2034, registering a CAGR of 11.5%. This growth trajectory is underpinned by several key factors, including the increasing prevalence of hereditary transthyretin amyloidosis (hATTR), advancements in drug delivery technologies, and a growing focus on personalized medicine. The demand for...
0 Comments 0 Shares 7 Views 0 Reviews